|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00876 KAISA HEALTH
Nominal 
1.875 +0.010 (+0.536%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 284,589 | -15.852% | 139,112 | 185,357 | 185,882 | 191,499 |
| Cost of Sales | (176,755) | -10.683% | (88,468) | (103,499) | (104,809) | (108,934) |
| Gross Profit | 107,834 | -23.142% | 50,644 | 81,858 | 81,073 | 82,565 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | (64,129) | |
| Change in FV & Impairment on Others | (16,120) | -- | 7,459 | (29,838) | (25,310) | (41,237) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | 69,391 | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (67,183) | -- | (46,945) | (48,681) | 6,046 | (170,963) | |
| Taxation | 4,706 | -- | 97 | (1,919) | 104 | (1,169) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,309 | -- | 170 | 4,245 | 1,318 | 48,814 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (60,168) | 677.465% | (46,678) | (46,355) | 7,468 | (123,318) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 11,115 | -40.852% | (189) | (536) | 594 | 4,725 |
| Depreciation & Amortisation | 27,906 | 5.773% | 12,993 | 15,174 | 17,887 | 31,312 |
| Directors' Emoluments | -- | -- | -- | 17,771 | 18,105 | 23,123 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -62.000 | 708.344% | -46.500 | -46.000 | 7.500 | -122.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.009) | (0.007) | (0.007) | (0.012) |
| NBV per share ($) | (3.115) | -- | 4.000038 | 4.275497 | 4.878991 | 4.812729 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -60,168 |
| %Change | 677.465% |
| EPS / (LPS) | HKD -0.620 |
| NBV Per Share ($) | HKD -3.115 |